A Comparison of Disease Severity and Outcomes in COVID-19 Cases Taking Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Versus Other Antihypertensive Drugs

Objective In this study, we aimed to compare the severity and outcomes in hypertensive patients presenting with coronavirus disease 2019 (COVID-19) who were taking angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) and those who were on other antihypertensive drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullah, Muhammad, Khan, Khurshid, Javed, Munaza, Iqbal, Javeid, Waheed, Khalid, Akhtar, Muhammad Naeem, Khan Chachar, Aijaz Zeeshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887438/
https://www.ncbi.nlm.nih.gov/pubmed/33614350
http://dx.doi.org/10.7759/cureus.12757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887438/
https://www.ncbi.nlm.nih.gov/pubmed/33614350
http://dx.doi.org/10.7759/cureus.12757

Ejemplares similares